Search clinical trials for: Ibrutinib and Thalidomide
Total 272440 results
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Recurrent Chronic Lymphocytic LeukemiaUnited States
-
University Hospital, CaenLaphalCompleted
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedRecurrent Uterine Corpus Sarcoma | Uterine Corpus LeiomyosarcomaUnited States
-
CelgeneCompletedClinical Pharmacology, Healthy Volunteer StudyUnited States
-
First Affiliated Hospital, Sun Yat-Sen UniversityCompleted
-
University Hospital, LilleCompleted
-
Peking Union Medical College HospitalRecruitingLangerhans Cell HistiocytosisChina
-
Robert LowskyNational Cancer Institute (NCI); Janssen, LP; The Leukemia and Lymphoma Society; Rising Tide FoundationCompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
Pharmacyclics LLC.CompletedMultiple MyelomaUnited States
-
Emory UniversityNovartisTerminatedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Dana-Farber Cancer InstituteAcetylon Pharmaceuticals IncorporatedActive, not recruitingRecurrent Chronic Lymphoid LeukemiaUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingLymphoma, Mantle-CellUnited States, China, Spain, Belgium, Canada, Australia, Czechia, Italy, Taiwan, Germany, Japan, New Zealand, United Kingdom, Denmark, Brazil, Israel, France, Netherlands, Korea, Republic of, Poland, Hungary, Austria, Switzerland, Por... and more
-
Memorial Sloan Kettering Cancer CenterPharmacyclics LLC.Active, not recruitingMarginal Zone LymphomaUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedChronic Graft-versus-host-diseaseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
George A. Kaysen, M.D.Beth Israel Medical CenterTerminatedHypoalbuminemiaUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityCompletedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
University of ArkansasTerminatedMultiple MyelomaUnited States
-
University of UtahJanssen, LPWithdrawnAcute Lymphoblastic LeukemiaUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Intergroupe Francophone du MyelomeCompleted
-
Nantes University HospitalCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Cutaneous MelanomaUnited States
-
Federation Francophone de Cancerologie DigestiveCentre Hospitalier Universitaire DijonCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
Janssen Pharmaceutical K.K.CompletedWaldenstrom MacroglobulinemiaJapan
-
National Cancer Institute (NCI)CompletedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Recurrent B-Cell Prolymphocytic Leukemia | Refractory B-Cell Prolymphocytic LeukemiaUnited States
-
Mayo ClinicActive, not recruitingMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Melanoma | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Zhejiang Cancer HospitalUnknownMetastatic Breast CancerChina
-
Korean Multiple Myeloma Working PartyCelgene CorporationUnknown
-
Swiss Group for Clinical Cancer ResearchNordic Lymphoma GroupTerminatedFollicular LymphomaSweden, Finland, Denmark, Norway, Switzerland, Austria
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingClassical Hodgkin LymphomaUnited States
-
Incyte CorporationCompletedB-cell LymphomaUnited States, Spain, Italy
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, France, Poland, Belgium, Germany, Spain, Argentina, Colombia, Israel, Portugal, Russian Federation, Turkey, Ukraine, Canada, Greece, Sweden, Korea, Republic of, United Kingdom, Brazil, Mexico, Czechia
-
CelgeneCompletedCentral Nervous System Neoplasms | MedulloblastomaUnited States, Italy, France, Spain, United Kingdom
-
Pharmacyclics Switzerland GmbHJanssen Research & Development, LLCCompletedMultiple MyelomaSpain, Germany, Turkey, Greece, Italy, Czechia
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityUnknownChronic Radiation Proctitis
-
CelgeneCompletedMultiple MyelomaFrance, Belgium
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedBrain Stem Neoplasms, Primary | Neoplasms, Brain StemUnited States
-
Case Comprehensive Cancer CenterCompletedMyelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Chonnam National University HospitalUnknownMultiple MyelomaKorea, Republic of
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedMultiple Myeloma | Plasma Cell MyelomaUnited States
-
Grupo de Estudos Multicentricos em Onco-HematologiaCompletedMultiple Myeloma | Effects of Chemotherapy
-
Brian JonasNational Cancer Institute (NCI); Celgene; Pharmacyclics LLC.CompletedPreviously Treated Myelodysplastic Syndrome | Myelodysplastic Syndrome | Therapy-Related Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic SyndromeUnited States
-
Mayo ClinicNot yet recruitingChronic Graft Versus Host Disease | Hematopoietic and Lymphatic System NeoplasmUnited States